US-based surgical and therapeutic solutions provider Vycor Medical has obtained Hong Kong patent for its VBAS minimally invasive brain access system.
VBAS, a suite of clear cylindrical disposable devices, is designed to provide neurosurgeons with a stable, minimally invasive working channel to access targeted sites within the brain such as tumors.
The company said the ISO 13485:2003 compliant VBAS device has FDA 510(k) clearance for brain and spine surgeries and regulatory approvals for brain surgeries in Australia, Canada, China, Europe, Japan, Korea and Russia.
Vycor president David Cantor said the addition of the Hong Kong patent builds upon the company's significant IP portfolio surrounding the VBAS device.
"Outside the U.S., there are approximately 800,000 neurosurgical procedures annually which can be addressed by our existing VBAS product line which equates to a market potential of approximately $285 million," Cantor added.
"We currently have distribution agreements in place for VBAS in Australia, China, Germany, Greece, Holland, Hong Kong, Italy, Japan, Korea, Spain, Sweden and the UK.
"We expect to be entering into a number of additional international distribution agreements this year."
The company already has distribution agreement in place with Devon Medical, which covers Hong Kong and China.
